Psilocybin study in healthy volunteers with psychedelic interest
Treatments studied
This study gives a single dose of psilocybin to healthy adults who are curious about psychedelics but have little to no past use. Researchers will measure how it affects your mood, brain activity, and body chemistry to understand its effects better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 65 years old
- You have never used a classic psychedelic (like LSD, psilocybin, or ayahuasca) or dissociative drug (like ketamine or PCP), or only once more than 5 years ago with no bad effects
- You are in good physical health, with a body mass index between 18 and 34, and a waist size under 90 cm for women or 97 cm for men
- You have no current or past drug or alcohol dependence, no serious mental health conditions (like schizophrenia or bipolar disorder), and no heart or other medical problems that could be made worse by psilocybin
- You are not taking certain medications (like antidepressants, lithium, or St. John's Wort) and can use reliable birth control if you could become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how music affects your experience with psilocybin, a psychedelic substance. It may help researchers understand how to create the best setting for psilocybin therapy.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
This study tests how certain psychoactive substances affect your mind and body. It is looking for healthy volunteers to take part in supervised sessions to explore the effects of these drugs.
This trial tests how psilocybin, a psychedelic substance, affects your thinking, memory, and brain activity. Researchers want to understand these effects in healthy adults who have used psychedelics before.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This trial tests whether a combination of psilocybin and D-serine is safe and affects mood and thinking. It's for healthy people who want to help research on psychedelics.
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.